Thomas E. Lew
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 21
- Chronic Lymphocytic Leukemia Research 21
-
- Lymphoma Diagnosis and Treatment 12
- Co-authors
- John F. Seymour (20 shared papers)Constantine S. Tam (16 shared papers)Andrew W. Roberts (12 shared papers)Mary Ann Anderson (16 shared papers)David Westerman (9 shared papers)Piers Blombery (11 shared papers)David C.S. Huang (8 shared papers)Ella R. Thompson (5 shared papers)
- Journals
- Blood (9 papers)Blood Advances (4 papers)Journal of Hematology & Oncology (1 paper)British Journal of Haematology (1 paper)BMC Nephrology (1 paper)
- Partner nations
- AustraliaUnited StatesTaiwan
In The Last Decade
Thomas E. Lew
33 papers receiving 920 citations
Thomas E. Lew's Hit Papers
Peers
Comparison fields: 5 of 53
- Genetics 584
- Pathology and Forensic Medicine 392
- Hematology 199
- Immunology 177
- Oncology 155
Countries citing papers authored by Thomas E. Lew
This map shows the geographic impact of Thomas E. Lew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Lew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Lew more than expected).
Fields of papers citing papers by Thomas E. Lew
This network shows the impact of papers produced by Thomas E. Lew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Lew. The network helps show where Thomas E. Lew may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Lew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia Hit paper breakdown → | 2018 | 287 |
| 2 | 2017 | 113 | |
| 3 | 2022 | 65 | |
| 4 | 2020 | 62 | |
| 5 | 2021 | 50 | |
| 6 | 2021 | 49 | |
| 7 | 2022 | 33 | |
| 8 | 2020 | 31 | |
| 9 | 2013 | 25 | |
| 10 | 2023 | 21 | |
| 11 | 2021 | 18 | |
| 12 | 2021 | 18 | |
| 13 | 2020 | 18 | |
| 14 | 2016 | 18 | |
| 15 | 2017 | 16 | |
| 16 | 2019 | 15 | |
| 17 | 2016 | 15 | |
| 18 | 2018 | 13 | |
| 19 | 2024 | 10 | |
| 20 | 2018 | 9 |
About Thomas E. Lew
Thomas E. Lew is a scholar working on Genetics, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Hematology and Oncology, having authored 34 papers that have together received 928 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (12 papers), Chronic Myeloid Leukemia Treatments (6 papers), Advanced Breast Cancer Therapies (6 papers), Diabetes Management and Research (3 papers), Acute Myeloid Leukemia Research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Genetics (584 citations), Pathology and Forensic Medicine (392 citations), Hematology (199 citations), Immunology (177 citations) and Oncology (155 citations). Thomas E. Lew has collaborated with scholars based in Australia, United States and Taiwan. Frequent co-authors include John F. Seymour, Constantine S. Tam, Andrew W. Roberts, Mary Ann Anderson, David Westerman, Piers Blombery, David C.S. Huang, Ella R. Thompson, Tamia Nguyen and Sasanka M. Handunnetti. Their work appears in journals such as Blood, Blood Advances, Journal of Hematology & Oncology, British Journal of Haematology and BMC Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.